TABLE III.
Five-Year Hazard Ratio of All-Cause Mortality Among Tracheal Squamous Cell Carcinoma Patients According to Treatment Modality by Localized and Advanced Staging.
| Characteristic | Localized (n = 248) | Regional Extension (n = 222) | ||
|---|---|---|---|---|
|
|
|
|||
| Adjusted Cox HR* (95% CI) | P Value | Adjusted Cox HR* (95% CI) | P Value | |
|
| ||||
| Treatment modality | ||||
| No treatment | 1.00 (Ref) | 1.00 (Ref) | ||
| Limited surgery | 0.56 (0.29–1.07) | 0.08 | 0.82 (0.38–1.78) | 0.62 |
| Curative surgery | 0.38 (0.18–0.79) | 0.01 | 0.35 (0.17–0.76) | 0.01 |
| Limited surgery + AT | 0.53 (0.28–1.02) | 0.06 | 0.38 (0.21 −0.7) | <0.01 |
| Cur surgery + AT | 0.39 (0.17–0.86) | 0.02 | 0.32 (0.16–0.66) | <0.01 |
| RT | 0.72 (0.39–1.33) | 0.29 | 0.48(0.29–0.81) | 0.01 |
| CRT | 0.55 (0.3–1.00) | 0.05 | 0.34 (0.21 −0.56) | <0.01 |
Adjusted for sex, age, insurance type, comorbidities, treatment facility type, and palliative treatment.
CI = confidence interval; HR = hazard ratio.